Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFR) non-small cell lung cancer (NSCLC) who have received prior systemic therapies, ...

EGFR, epidermal growth factor receptor, is a protein found on the surface of your cells that makes them grow. If you have non-small-cell lung cancer (NSCLC), your cancer might carry certain ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...

A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for ...

However, screening can be a challenging and time-consuming process. The team tested their new method to screen drugs that can ...

That means they’re the main cause of your cancer growth and cell division. Epidermal growth factor receptor (EGFR) mutation is one biomarker doctors look for during testing. EGFR is a protein on ...

No writing assistance was utilized in the production of this manuscript. Ligand-mediated EGF receptor (EGFR) targeting of nanovehicles is an effective way for cancer cell-selective delivery of ...

US FDA-approved drugs; for more information see [15]. EGFR: EGF receptor; FGFR: FGF receptor; NSCLC: Non-small-cell lung cancer; VEGFR: VEGF receptor. Gefitinib [53] Reversible EGFR TKI US FDA ...

Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...